메뉴 건너뛰기




Volumn 77, Issue 2, 2012, Pages 460-463

Differential sensitivities to tyrosine kinase inhibitors in NSCLC harboring EGFR mutation and ALK translocation

Author keywords

ALK translocation; EGFR mutation; Non small cell lung cancer

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; CRIZOTINIB; EPIDERMAL GROWTH FACTOR RECEPTOR; GEFITINIB;

EID: 84863776935     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2012.04.012     Document Type: Article
Times cited : (84)

References (18)
  • 1
    • 2342471392 scopus 로고    scopus 로고
    • Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
    • Lynch T.J., Bell D.W., Sordella R., Gurubhagavatula S., Okimoto R.A., Brannigan B.W., et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004, 350:2129-2139.
    • (2004) N Engl J Med , vol.350 , pp. 2129-2139
    • Lynch, T.J.1    Bell, D.W.2    Sordella, R.3    Gurubhagavatula, S.4    Okimoto, R.A.5    Brannigan, B.W.6
  • 2
    • 34547638047 scopus 로고    scopus 로고
    • Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer
    • Soda M., Choi Y.L., Enomoto M., Takada S., Yamashita Y., Ishikawa S., et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 2007, 448:561-566.
    • (2007) Nature , vol.448 , pp. 561-566
    • Soda, M.1    Choi, Y.L.2    Enomoto, M.3    Takada, S.4    Yamashita, Y.5    Ishikawa, S.6
  • 5
    • 70349336416 scopus 로고    scopus 로고
    • Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK
    • Shaw A.T., Yeap B.Y., Mino-Kenudson M., Digumarthy S.R., Costa D.B., Heist R.S., et al. Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK. J Clin Oncol 2009, 27:4247-4253.
    • (2009) J Clin Oncol , vol.27 , pp. 4247-4253
    • Shaw, A.T.1    Yeap, B.Y.2    Mino-Kenudson, M.3    Digumarthy, S.R.4    Costa, D.B.5    Heist, R.S.6
  • 7
    • 77954399760 scopus 로고    scopus 로고
    • Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression
    • Zhang X., Zhang S., Yang X., Yang J., Zhou Q., Yin L., et al. Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression. Mol Cancer 2010, 9:188.
    • (2010) Mol Cancer , vol.9 , pp. 188
    • Zhang, X.1    Zhang, S.2    Yang, X.3    Yang, J.4    Zhou, Q.5    Yin, L.6
  • 8
    • 80052793410 scopus 로고    scopus 로고
    • A novel ALK secondary mutation and EGFR signaling cause resistance to ALK kinase inhibitors
    • Sasaki T., Koivunen J., Ogino A., Yanagita M., Nikiforow S., Zheng W., et al. A novel ALK secondary mutation and EGFR signaling cause resistance to ALK kinase inhibitors. Cancer Res 2011, 71:6051-6060.
    • (2011) Cancer Res , vol.71 , pp. 6051-6060
    • Sasaki, T.1    Koivunen, J.2    Ogino, A.3    Yanagita, M.4    Nikiforow, S.5    Zheng, W.6
  • 9
    • 78650950138 scopus 로고    scopus 로고
    • EGFR and EML4-ALK gene mutations in NSCLC: a case report of erlotinib-resistant patient with both concomitant mutations
    • Tiseo M., Gelsomino F., Boggiani D., Bortesi B., Bartolotti M., Bozzetti C., et al. EGFR and EML4-ALK gene mutations in NSCLC: a case report of erlotinib-resistant patient with both concomitant mutations. Lung Cancer 2011, 71:241-243.
    • (2011) Lung Cancer , vol.71 , pp. 241-243
    • Tiseo, M.1    Gelsomino, F.2    Boggiani, D.3    Bortesi, B.4    Bartolotti, M.5    Bozzetti, C.6
  • 10
    • 78650499456 scopus 로고    scopus 로고
    • Good response to gefitinib in lung adenocarcinoma harboring coexisting EML4-ALK fusion gene and EGFR mutation
    • Kuo Y.W., Wu S.G., Ho C.C., Shih J.Y. Good response to gefitinib in lung adenocarcinoma harboring coexisting EML4-ALK fusion gene and EGFR mutation. J Thorac Oncol 2010, 5:2039.
    • (2010) J Thorac Oncol , vol.5 , pp. 2039
    • Kuo, Y.W.1    Wu, S.G.2    Ho, C.C.3    Shih, J.Y.4
  • 11
    • 80054911665 scopus 로고    scopus 로고
    • Lung adenocarcinoma with concurrent exon 19 EGFR mutation and ALK rearrangement responding to erlotinib
    • Popat S., Vieira de Araújo A., Min T., Swansbury J., Dainton M., Wotherspoon A., et al. Lung adenocarcinoma with concurrent exon 19 EGFR mutation and ALK rearrangement responding to erlotinib. J Thorac Oncol 2011, 6:1962.
    • (2011) J Thorac Oncol , vol.6 , pp. 1962
    • Popat, S.1    Vieira de Araújo, A.2    Min, T.3    Swansbury, J.4    Dainton, M.5    Wotherspoon, A.6
  • 12
    • 37549050186 scopus 로고    scopus 로고
    • Molecular changes of epidermal growth factor receptor (EGFR) and KRAS and their impact on the clinical outcomes in surgically resected adenocarcinoma of the lung
    • Kim Y.T., Kim T., Lee D.S., Park S.J., Park J., Seo S.J., et al. Molecular changes of epidermal growth factor receptor (EGFR) and KRAS and their impact on the clinical outcomes in surgically resected adenocarcinoma of the lung. Lung Cancer 2008, 59:111-118.
    • (2008) Lung Cancer , vol.59 , pp. 111-118
    • Kim, Y.T.1    Kim, T.2    Lee, D.S.3    Park, S.J.4    Park, J.5    Seo, S.J.6
  • 13
    • 77649308276 scopus 로고    scopus 로고
    • Gene copy number leads to shorter survival in patients with non-small cell lung cancer
    • Go H., Jeon Y.K., Park H.J., Sung S.W., Seo J.W., Chung D.H., et al. gene copy number leads to shorter survival in patients with non-small cell lung cancer. J Thorac Oncol 2010, 5:305.
    • (2010) J Thorac Oncol , vol.5 , pp. 305
    • Go, H.1    Jeon, Y.K.2    Park, H.J.3    Sung, S.W.4    Seo, J.W.5    Chung, D.H.6
  • 14
    • 32944468710 scopus 로고    scopus 로고
    • A rapid and sensitive enzymatic method for epidermal growth factor receptor mutation screening
    • Janne P.A., Borras A.M., Kuang Y., Rogers A.M., Joshi V.A., Liyanage H., et al. A rapid and sensitive enzymatic method for epidermal growth factor receptor mutation screening. Clin Cancer Res 2006, 12:751-758.
    • (2006) Clin Cancer Res , vol.12 , pp. 751-758
    • Janne, P.A.1    Borras, A.M.2    Kuang, Y.3    Rogers, A.M.4    Joshi, V.A.5    Liyanage, H.6
  • 15
    • 0037025173 scopus 로고    scopus 로고
    • Addiction to oncogenes - the Achilles heal of cancer
    • Weinstein I.B. Addiction to oncogenes - the Achilles heal of cancer. Science 2002, 297:63.
    • (2002) Science , vol.297 , pp. 63
    • Weinstein, I.B.1
  • 16
    • 33746388176 scopus 로고    scopus 로고
    • "Oncogenic Shock": explaining oncogene addiction through differential signal attenuation
    • Sharma S.V., Fischbach M.A., Haber D.A., Settleman J. "Oncogenic Shock": explaining oncogene addiction through differential signal attenuation. Clin Cancer Res 2006, 12:4392s-4395s.
    • (2006) Clin Cancer Res , vol.12
    • Sharma, S.V.1    Fischbach, M.A.2    Haber, D.A.3    Settleman, J.4
  • 17
    • 34249075147 scopus 로고    scopus 로고
    • MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling
    • Engelman J.A., Zejnullahu K., Mitsudomi T., Song Y., Hyland C., Park J.O., et al. MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling. Science 2007, 316:1039.
    • (2007) Science , vol.316 , pp. 1039
    • Engelman, J.A.1    Zejnullahu, K.2    Mitsudomi, T.3    Song, Y.4    Hyland, C.5    Park, J.O.6
  • 18
    • 52749099497 scopus 로고    scopus 로고
    • Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer
    • Linardou H., Dahabreh I.J., Kanaloupiti D., Siannis F., Bafaloukos D., Kosmidis P., et al. Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer. Lancet Oncol 2008, 9:962-972.
    • (2008) Lancet Oncol , vol.9 , pp. 962-972
    • Linardou, H.1    Dahabreh, I.J.2    Kanaloupiti, D.3    Siannis, F.4    Bafaloukos, D.5    Kosmidis, P.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.